A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signalingYlenia Ferrara, Antonella Zannetti|Cell Communication and Signaling|2025Cited by 8